Retrospective Analysis of Safety and Efficacy of Low-Dose Docetaxel 60 mg/m2 in Advanced Non???Small Cell Lung Cancer Patients Previously Treated With Platinum-Based Chemotherapy

Previously Treated

The Safety and Efficacy of Second-line Single Docetaxel (75 mg/m2) Therapy in Advanced Non-Small Cell Lung Cancer Patients who were Previously Treated with Platinum-based Chemotherapy

Cancer Research and Treatment ◽

10.4143/crt.2005.37.6.339 ◽

2005 ◽

Vol 37 (6) ◽

pp. 339 ◽

Cited By ~ 4

Author(s):

Byoung Yong Shim ◽

Chi Hong Kim ◽

So Hyang Song ◽

Meyung Im Ahn ◽

Eun Jung Hong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Second Line ◽

Small Cell Lung ◽

Safety And Efficacy ◽

Lung Cancer Patients ◽

Previously Treated

Atezolizumab plus carboplatin and etoposide in small cell lung cancer patients previously treated with platinum-based chemotherapy

Investigational New Drugs ◽

10.1007/s10637-020-00983-6 ◽

2020 ◽

Author(s):

Hidenobu Ishii ◽

Koichi Azuma ◽

Akihiko Kawahara ◽

Norikazu Matsuo ◽

Takaaki Tokito ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Previously Treated

Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy

European Journal of Cancer ◽

10.1016/j.ejca.2012.06.011 ◽

2012 ◽

Vol 48 (18) ◽

pp. 3378-3385 ◽

Cited By ~ 10

Author(s):

Eva Sodja ◽

Lea Knez ◽

Izidor Kern ◽

Tanja Ovčariček ◽

Aleksander Sadikov ◽

...

Keyword(s):

Lung Cancer ◽

Treatment Outcome ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Ercc1 Expression

Selected patients can benefit more from the management of etoposide and platinum-based chemotherapy and thoracic irradiation-a retrospective analysis of 707 small cell lung cancer patients

Oncotarget ◽

10.18632/oncotarget.14395 ◽

2016 ◽

Vol 8 (5) ◽

pp. 8657-8669 ◽

Cited By ~ 10

Author(s):

Shoubo Cao ◽

Shi Jin ◽

Jing Shen ◽

Jingyan Cao ◽

Hua Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Retrospective Analysis ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Thoracic Irradiation ◽

Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2018.02.003 ◽

2018 ◽

Vol 15 ◽

pp. 21-31 ◽

Cited By ~ 3

Author(s):

Iván Galván-Femenía ◽

Marta Guindo ◽

Xavier Duran ◽

Sílvia Calabuig-Fariñas ◽

Josep Maria Mercader ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Prognostic Value ◽

Small Cell ◽

Genomic Profiling ◽

Advanced Stage ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Lymphocyte to monocyte ratio is associated with response to first-line platinum-based chemotherapy and prognosis of early-stage non-small cell lung cancer patients

Tumor Biology ◽

10.1007/s13277-015-4397-8 ◽

2015 ◽

Vol 37 (4) ◽

pp. 5285-5293 ◽

Cited By ~ 14

Author(s):

Ying-Jian Song ◽

Li-Xin Wang ◽

Yong-Qing Hong ◽

Zheng-Hong Lu ◽

Qiang Tong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Early Stage ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Lung Cancer Patients ◽

Lymphocyte To Monocyte Ratio ◽

Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

JNCI Journal of the National Cancer Institute ◽

10.1093/jnci/djr075 ◽

2011 ◽

Vol 103 (10) ◽

pp. 817-825 ◽

Cited By ~ 61

Author(s):

Xifeng Wu ◽

Yuanqing Ye ◽

Rafael Rosell ◽

Christopher I. Amos ◽

David J. Stewart ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Genome Wide Association Study ◽

Small Cell ◽

Genome Wide Association ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Genome Wide ◽

Immunonutritional Indices in Non-small-cell Lung Cancer Patients Receiving Adjuvant Platinum-based Chemotherapy

Anticancer Research ◽

10.21873/anticanres.15333 ◽

2021 ◽

Vol 41 (10) ◽

pp. 5157-5163

Author(s):

TAICHI MATSUBARA ◽

FUMIHIKO HIRAI ◽

MASAFUMI YAMAGUCHI ◽

MOTOHARU HAMATAKE

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Cancer Patients With EGFR Mutation

Clinical Lung Cancer ◽

10.1016/j.cllc.2020.01.011 ◽

2020 ◽

Vol 21 (3) ◽

pp. 273-280.e4 ◽

Cited By ~ 2

Author(s):

Ichidai Tanaka ◽

Masahiro Morise ◽

Ayako Miyazawa ◽

Yuta Kodama ◽

Yutaro Tamiya ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Egfr Mutation ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Potential Benefits

RICTORpolymorphisms affect efficiency of platinum-based chemotherapy in Chinese non-small-cell lung cancer patients

Pharmacogenomics ◽

10.2217/pgs-2016-0070 ◽

2016 ◽

Vol 17 (15) ◽

pp. 1637-1647 ◽

Cited By ~ 3

Author(s):

Shiming Wang ◽

Xiao Song ◽

Xiaoying Li ◽

Xueying Zhao ◽

Hongyan Chen ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽